Xebra Granted Trademarks for Its Cannabis Infused Beverage Brands in Latin America
Xebra Brands Ltd. (CSE: XBRA) has announced the granting of trademarks for its cannabis-infused beverage brands in various Latin American countries, including Argentina, Brazil, and Colombia. The trademarks include names such as MADCAP for soft drinks and VICIOUS CITRUS for lemonades, along with catchy slogans. This move supports Xebra's strategy to secure global trademark protection as cannabis legalization expands. The company is also focused on launching its products in Canada and completing agronomical evaluations in Colombia for future cannabis activities.
- Obtained trademarks for cannabis beverage brands in multiple Latin American countries.
- Trademarks include popular names and slogans expected to resonate with consumers.
- Supports long-term strategy for global brand protection as cannabis legalization expands.
- None.
VANCOUVER, BC, Feb. 10, 2022 /PRNewswire/ - Xebra Brands Ltd. ("Xebra") (CSE: XBRA:) (OTCQB: XBRAF) (FSE: 9YC), a cannabis company, is pleased to announce that in addition to the trademark grants previously reported in Mexico, Xebra has also been granted trademarks for its cannabis infused beverage brands, in the following Latin American countries: Argentina, Brazil, Chile, Colombia, Ecuador, Jamaica, Peru and Uruguay. Trademarks granted include MADCAP (soft drinks), and the slogan "Crazy Good", HOLAHI (iced teas) and the slogan "It's High Time", HIGHJACK (energy drinks), and the slogan "Enjoy the Trip", VICIOUS CITRUS (lemonades), and the slogan "Lemonade for Renegades", HIGHCASTLE (waters), and the slogan "Drink Like a King", and CONQUER (sports beverage).
The latest grants further Xebra's objective to obtain trademark protection for its unique brands globally, in countries where cannabis legalization or decriminalization has occurred, or is foreseeable.
Additional grants are expected to be announced in the future.
ABOUT XEBRA
On December 1st, 2021, Xebra was granted a cannabis injunction by the Mexican Supreme Court, which positions it as a first mover in the Mexican CBD and CBG sector. Xebra has also been selected by the Dutch government, out of a competitive pool of applicants, as one of only five companies to compete for two exclusive licenses to cultivate medicinal cannabis (including THC) in the Netherlands, with an initial six-year guaranteed government contract for each successful party estimated at ~CDN
ON BEHALF OF THE BOARD,
Rodrigo Gallardo
President
For more information contact:
+1 (604) 418-6560
ir@xebrabrands.com
Certain information contained in this press release constitutes forward-looking statements under applicable securities laws. Any statements that are not statements of historical fact may be deemed to be forward-looking statements, these include, without limitation, statements regarding Xebra Brands Ltd.'s expectations in respect of its ability to successfully execute its business plan or business model; its ability to provide economic, environmental, social, or any benefits of any type, in the communities it operates in or may operate it in the future; its ability to be a first mover in a country, or to obtain or retain government licenses, permits or authorizations in general, or specifically in Mexico, Colombia, Canada, the Netherlands, or elsewhere; its ability to successfully apply for and obtain trademarks and other intellectual property in any jurisdiction; its ability to be cost competitive; its ability to cultivate, grow, or process hemp or cannabis in Mexico, Colombia, Canada, the Netherlands, or elsewhere and related plans; financial, operational, or any other term relating to the Company's participation in the Dutch trial medicinal cannabis cultivation; its ability to manufacture cannabis beverages, wellness products, or other products; its ability to commercialize or sell cannabis beverages, wellness products, or other products, in Mexico, Colombia, Canada, the Netherlands, or elsewhere; its ability to commercialize or to sell Vicious Citrus Lemonade in 2022 or at any time, in any jurisdiction; its ability to commercialize or to sell Elements wellness products in any jurisdiction at any time; its ability to create wellness products that have a therapeutic effect or benefit; plans for future growth and the direction of the business; financial projections including expected revenues, gross profits, and EBITDA (which is a non-GAAP financial measure); plans to increase product volumes, the capacity of existing facilities, supplies from third party growers and contractors; expected growth of the cannabis industry generally; management's expectations, beliefs and assumptions; events or developments that XEBRA expects to take place in the future; general economic conditions; and other risk factors described in the prospectus of the Company dated September 30, 2021. All statements, other than statements of historical facts, are forward-looking information and statements. The words "aim", "believe", "expect", "anticipate", "contemplate", "target", "intends", "continue", "plans", "budget", "estimate", "may", "will", and similar expressions identify forward-looking information and statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by XEBRA as of the dates of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements. Such factors include, but are not limited to, the inability of XEBRA to generate sufficient revenues or to raise sufficient funds to carry out its business plan; changes in government legislation, taxation, controls, regulations and political or economic developments in various countries; risks associated with agriculture and cultivation activities generally, including inclement weather, access to supply of seeds, poor crop yields, and spoilage; compliance with import and export laws of various countries; significant fluctuations in cannabis prices and transportation costs; the risk of obtaining necessary licenses and permits; inability to identify, negotiate and complete a potential acquisition for any reason; the ability to retain key employees; dependence on third parties for services and supplies; non-performance by contractual counter-parties; general economic conditions; and the continued growth in global demand for cannabis products and the continued increase in jurisdictions legalizing cannabis; and the timely receipt of regulatory approval for license applications. The foregoing list is not exhaustive and XEBRA undertakes no obligation to update or revise any of the foregoing except as required by law. Many of these uncertainties and contingencies could affect XEBRA's actual performance and cause its actual performance to differ materially from what has been expressed or implied in any forward-looking statements made by, or on behalf of, XEBRA. Readers are cautioned that forward-looking statements are not guarantees of future performance and readers should not place undue reliance on such forward-looking statements. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those set out in such statements.
View original content to download multimedia:https://www.prnewswire.com/news-releases/xebra-granted-trademarks-for-its-cannabis-infused-beverage-brands-in-latin-america-301479422.html
SOURCE Xebra Brands Ltd.
FAQ
What trademarks did Xebra Brands obtain in Latin America?
In which countries did Xebra receive trademark grants?
What is the significance of Xebra's trademark grants?
When will Xebra launch its products in Canada?
What additional plans does Xebra have in Colombia?
